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Detection of MUM1+ cells in follicular lymphoma (FL) tissues was previously found
to be associated with poor prognosis in a single report, whereas the usefulness of
Ki-67 immunostaining remains debated. Our goal was to establish whether these
markers have predictive value for patients with FL. We analyzed MUM1 and Ki-67
expression using immunohistochemistry in biopsy samples from 434 patients from
the PRIMA randomized trial. The MUM1 prognostic value was then validated in a
cohort of 138 patients from the FL2000 randomized trial, using the optimal cutoff
value obtained from the PRIMA cohort. The surface of positive staining was
quantified using computerized image analysis. In the PRIMA cohort, both high levels
of MUM1 positivity (cutoff value of 0.80%) and high levels of Ki-67 positivity (cutoff
value of 10.25%) were significantly associated with a shorter progression-free
survival (PFS) (P = .004 and P = .007 for MUM1 and Ki-67, respectively). In a
multivariate Cox proportional hazards regression model, only MUM1 retained a
statistical significance (hazards ratio 1.56; 95% confidence interval, 1.02-2.37; P =
.038) after adjustment for the maintenance arm of treatment and the follicular
lymphoma international prognostic index score. In the FL2000 cohort, high levels of
MUM1 positivity were significantly associated to a shorter PFS (P = .004) and to a
trend toward a shorter overall survival (P = .043). This remained significant using a
multivariate Cox regression model after adjustment for the follicular lymphoma
international prognostic index and the treatment arm for PFS (P = .016). These
results show that MUM1 is a strong and robust predictive immunohistochemical
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